会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • STAUROSPORIN DERIVATIVES
    • 星孢菌素衍。
    • EP0383919A1
    • 1990-08-29
    • EP89901739.6
    • 1989-01-30
    • KYOWA HAKKO KOGYO CO., LTD.
    • MURAKATA, ChikaraSATO, AkiraKASAI, MasajiMORIMOTO, MakotoAKINAGA, Shiro
    • C07D498/22
    • C07D498/22A61K38/005C07D211/46C07D417/06C07D417/14C07K5/0227C07K5/06139
    • Novel staurosporin derivatives represented by formula (I) (wherein R 1 represents hydrogen, lower alkyl, formyl or amino, R 2 represents hydrogen, formyl, lower alkanoyl or a group formed by removing a hydroxy moiety from the carboxyl group of an a-amino acid whose amino group may optionally be protected, one of X 1 and X 2 represents hydrogen and the other represents hydrogen, hydroxy, lower alkoxy or lower alkylthio, or X' and X 2 are taken together to form oxygen, provided that, when R 1 and R 2 are both hydrogen atoms and one of X 1 and X 2 is hydrogen, the other represents a group other than hydrogen or hydroxy) and their pharmacologically acceptable salts are disclosed. These compounds inhibit protein kinase C and have a cell growth inhibiting activity.
    • 由式(I)表示的新型星形孢菌素衍生物(其中R 1表示氢,低级烷基,甲酰基或氨基,R 2表示氢,甲酰基,低级烷酰基或通过从羧基的羧基除去羟基而形成的基团 其氨基可以任选被保护的α-氨基酸,X 1和X 2之一表示氢,另一个表示氢,羟基,低级烷氧基或低级烷硫基,或X 1和X 2 一起形成氧,条件是当R 1和R 2都是氢原子并且X 1和X 2中的一个是氢时,另一个表示氢或羟基以外的基团) 并公开了其药理学上可接受的盐。 这些化合物抑制蛋白激酶C并具有细胞生长抑制活性。
    • 3. 发明公开
    • DERIVATIVES OF PHYSIOLOGICALLY ACTIVE SUBSTANCE K-252
    • DERIVATE DES PHYSIOLOGISCH AKTIVEN MITTELS K-252。
    • EP0303697A1
    • 1989-02-22
    • EP87901672.3
    • 1987-03-09
    • KYOWA HAKKO KOGYO CO., LTD.
    • MURAKATA, ChikaraSATO, AkiraTAKAHASHI, MitsuruKOBAYASHI, EijiMORIMOTO, MakotoAKINAGA, ShiroHIRATA, TadashiMOCHIDA, KenichiKASE, HiroshiYAMADA, KojiIWAHASHI, Kazuyuki
    • C07D498/22A61K31/55
    • C07D498/22
    • Novel derivatives of K-252 ((8R', 9S*, 11S')-(-)-9-hydroxy-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro-8,11-epoxy-1H,8H,11H-2,7b,11a-triazadibenzo[a,g]cycloocta[cde]trinden-1-one) represented by formula (l) (wherein W 1 , W 2 , R 1 , R 2 , R 3 , R 4 , X, and Y represent various substituents) are disclosed. These compounds are physiologically active substances having a protein kinase C-inhibiting activity and an oncostatic activity, thus being useful as medicines.
    • 抗生素K-252衍生物。 式(I)的化合物是新的:在(I)中,R 1和R 3是OH,低级烷氧基或氨基,或R 3是H,R 1是H,Me,OH,Br,Cl,羟甲基,NR 5 R 6等; R2是H或氨基; 一个或R 5 / R 6是H,另一个是H,氨基甲酰基或低级烷基氨基羰基,或者R 5和R 6都是低级烷基; R4是H,C1,氨基甲酰基,低级烷基,氨基或-CH2CH2R7; R7是Br,氨基,羟基,二(低级烷基)氨基或羟基。 低级烷基氨基; W1和W2为H或一起为= O; X是H,甲酰基,低级烷氧基羰基,-CONR 8 R 9,-CH 2 A或-CH = NR 12; R8和R9是H,低级烷基,羟基。 低级烷基或R8是H,R9是OH; A是OH,叠氮基,低级烷硫基,低级烷基磺酰基,-NR10R11,-N = CHNMe2,-OCOCH2CH2COOH或2-四氢吡喃基氧基; R10和R11都是H或一个是H,低级烷基,芳基,羧基 - 低级烷基等,xycar,另一个是低级烷基(选择C1-substd)。 或R 10和R 11一起为-CH 2 CH 2 -B-CH 2 CH 2 - ; B是亚甲基,-NH-,S或O; R 12是OH,氨基,胍基或2-咪唑基氨基; Y是OH或氨基甲酰氧基; X和Y可以是(-XY-)-O-,-CH2O-,-CH2OCOO-,-CH2-O-CS-O-,-CH2-NR13-COO-,-CH2-N = CR14-O- 或-CH 2 -NH-CS-O-CH 2 -O-SO-O-; R 13是H,低级烷基,芳基,甲酰基甲基,-CH 2 CHOH-CH 2 OH或-CH 2 CH = N-NH-C(= NH)-NH 2; R 14是低级烷基或低级烷硫基。 当W1 / W2 = 0时,R1 = R2 = R3 = H; 当R 4为低级烷基时,氨基或-CH 2 CH 2 R 7,则W1 / W2为= O。 当Y是氨基甲酰氧基时,R1 = R2 = R3 = W1 = W2 = H,R4是氨基甲酰基,X是低级烷氧基羰基。 当R4为C1时,R1 = R2 = R3 = W1 = W2 = H,X为低级烷氧基羰基。 当X是H,甲酰基,-CONR 8 R 9,-CH 2 A或-CH = NR 12时,则R1 = R2 = R3 = W1 = W2 = R4 = H。 当X是-CONHOH时,则R1 = R2 = R3 = R4 = H。 = R4 = H。